glp-1 birth defects Study links use to some pregnancy risks — but the research has key caveats GLP-1-Mediated Pregnancy and Neonatal Complications

!Safety note The FDA has reviewed reports of suicidal thoughts or actions with GLP-1 receptor agonists and, in 2026, requested removal of suicidal ideation and behavior warning language from affected GLP-1 labels after finding no increased risk

Markets Europe Markets China Markets Asia Markets World Markets Currencies Prediction Markets Cryptocurrency Futures & Commodities Bonds Funds & ETFs Business Economy Finance Health & Science Media Real Estate Energy Climate Transportation Investigations Industrials Retail Wealth Sports Life Small Business Investing Personal Finance Fintech Financial Advisors Options Action ETF Street Buffett Archive Earnings Trader Talk Tech Cybersecurity AI Enterprise Internet Media Mobile Social Media CNBC Disruptor 50 Tech Guide Politics White House Policy Defense Congress Expanding Opportunity Europe Politics China Politics Asia Politics World Politics Video Latest Video Full Episodes Livestream Top Video Live Audio Europe TV Asia TV CNBC Podcasts CEO Interviews Digital Originals Watchlist Investing Club Trust Portfolio Analysis Trade Alerts Meeting Videos Homestretch Jim's Columns Education Subscribe PRO Pro News Josh Brown Mike Santoli Calls of the Day My Portfolio Livestream Full Episodes Stock Screener Market Forecast Options Investing Chart Investing Subscribe Livestream Make It select USA INTL Livestream Livestream Watchlist SIGN IN Create free account Markets Business Investing Tech Politics Video Watchlist Investing Club PRO Livestream watch now In this video LLY NVO Share CNBC Digital Original Video GLP-1 drugs have remained out of reach for many Americans on Medicare due to their cost

Beyond the scale, researchers in this phase notice improvements across multiple metabolic markers

Tirzepatide (Mounjaro) Tirzepatide is a dual GIP + GLP-1 receptor agonist

The Miami market for peptide therapy is competitive but mature, which keeps pricing aligned with national medical-clinic benchmarks

(2) a non-treatment group (saline), in which animals were exposed to noise and received a placebo saline solution